CLINICAL TRIAL

Referral for Cancer

Recruiting · Any Age · All Sexes · Philadelphia, PA

This study is evaluating whether a geriatric assessment screening tool can be incorporated into a busy oncology practice.

See full description

About the trial for Cancer

Eligible Conditions
Hematopoietic and Lymphoid Cell Neoplasm · Malignant Solid Neoplasms · Neoplasms

Treatment Groups

This trial involves 2 different treatments. Referral is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are in Phase 2 and have already been tested with other people.

Main TreatmentA portion of participants receive this new treatment to see if it outperforms the control.
Referral
OTHER
Questionnaire Administration
OTHER
Educational Intervention
OTHER
Screening Questionnaire Administration
OTHER
Control TreatmentAnother portion of participants receive the standard treatment to act as a baseline.

Eligibility

This trial is for patients born any sex of any age. There are 3 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
NURSES: Assigned to two designated cancer clinics at Sidney Kimmel Cancer Center (SKCC) Center City, the Renal Cell Carcinoma (RCC) and Lymphoma/myeloma clinics
View All
Odds of Eligibility
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: Up to 30 months
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: Up to 30 months.
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether Referral will improve 7 primary outcomes and 1 secondary outcome in patients with Cancer. Measurement will happen over the course of After self-administered learning module.

Overall assessment score: Post
AFTER SELF-ADMINISTERED LEARNING MODULE
The score will be a number between 1-20. The responses to two questions of primary interest, assessing their comfort caring for older adults and their comfort in administering the G8 tool, will be binary measurements. The overall assessment scores from pre- and post- self-administered learning module will be compared using paired Wilcoxon test.
Overall assessment score: Pre
BEFORE SELF-ADMINISTERED LEARNING MODULE
The score will be a number between 1-20. The responses to two questions of primary interest, assessing their comfort caring for older adults and their comfort in administering the G8 tool, will be binary measurements. The overall assessment scores from pre- and post- self-administered learning module will be compared using paired Wilcoxon test.
Time it took to screen
UP TO 30 MONTHS
Will be summarized by sample means, standard deviations and/or percentages.
Number of patients screened
UP TO 30 MONTHS
Will be summarized by sample means, standard deviations and/or percentages.
Positive predictive value of the G8
UP TO 30 MONTHS
The percentage of patients being determined as vulnerable/frail by Comprehensive Geriatric Assessment (CGA) at SAOC, i.e. the predictive positive value of G8, will be reported with its 95% confidence interval. The summary statistics of additional collected SAOC metrics including the Timed Up and Go test, prior history of falls, cognitive screen, depression screen, mortality prognostication, expected life expectancy, social distress thermometer, Mini Nutritional Assessment (MNA), presence of polypharmacy and inappropriate medications, and Eastern Cooperative Oncology Group (ECOG) score will be reported by means, standard deviations and percentages.
Number of completed SAOC visits
UP TO 30 MONTHS
Will be summarized by sample means, standard deviations and/or percentages.
See More

Patient Q & A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people get cancer a year in the United States?

Approximately two thousand new cancer cases are occurring per year in the United States. Men and women are diagnosed with cancer at the same rate. The rates and mortality for most cancer types are consistent with the rates and mortality rates in Western European countries, and with the rates and mortality in other developing nations.

Anonymous Patient Answer

What are the signs of cancer?

Symptoms of cancer are rare. The signs most commonly present to physicians as potentially abnormal include cough and weight loss. Aspirin and nonsteroidal anti-inflammatory drugs may mask symptoms of cancer. Other signs may include a persistent cough, night sweats, unexplained bone pain, and erythema nodosum (in children only). A family history of cancer and low urinary PSA levels do not indicate cancer at this stage.

Anonymous Patient Answer

What causes cancer?

Cancer is a collection of diseases caused by genetic changes in cells that can originate in any tissue/organ.\nThe causes of cancer come in all parts of the body. The risk factors and triggers that influence cancer risk can include environmental and host factors, as well as genetic factors.\n\n- Overview at MedNet\n- Overview at Cancer.

Anonymous Patient Answer

Can cancer be cured?

The available scientific literature does not support the contention that cancer can be cured in any significant, persistent form. The vast majority of published reports on cancer treatment are case reports and observational studies, and those few randomized controlled trials that exist are not prospective. These studies are limited by the short duration and lack of follow-up of most patients. Further, the studies that have been conducted do not include the most recent advances in the understanding of the molecular basis of metastatic cancer, and many of the treatments, which are not in widespread use, are based on outdated and unproven theories of cancer causation and treatment. In addition, the only controlled trials presently known which do include patients with metastatic cancer are not long-term.

Anonymous Patient Answer

What is cancer?

Cancer is the abnormal growth of cells that results in death due to their invasion into or metastasis beyond the sites of cancer as a direct or indirect result of gene abnormalities. It accounts for over 15% of all deaths; it is the second most common disease and the second leading cause of death in the USA.

Anonymous Patient Answer

What are common treatments for cancer?

Patients with [lung cancer](https://www.withpower.com/clinical-trials/lung-cancer) may not be receiving some treatments they might find advantageous in general, such as surgical resection with or without adjuvant chemotherapy or adjuvant radiotherapy. These data should raise questions about the benefit of some cancer drugs and treatments generally. Some patients may benefit from not receiving chemotherapy. The most common treatments for cancer were chemotherapy, radiation, and surgery. The most commonly recommended treatments for a given cancer were those with the most commonly recommended procedures.

Anonymous Patient Answer

Does cancer run in families?

The study supports the hypothesis that cancer is hereditary, at least in certain families. It is reasonable to consider cancer a multi genetic disorder. However, the familial nature remains an important characteristic of cancer and it is probable that families are not entirely representative of the disease.

Anonymous Patient Answer

Who should consider clinical trials for cancer?

In general, this is a very sensitive topic with respondents all with different opinions. The only concurrence was that when considering clinical trials, there are many important considerations including clinical outcomes, patient education, safety, cost and value - the main drivers of any treatment process. As it’s very obvious that many of these issues are difficult to reconcile, further evidence could be valuable. As you are probably aware, there is a great deal of consumer information available on clinical trials. How this information is used is a highly important factor as it can be as or even more important than evidence base if people are confused - a case in point would be the cancer drug Erbitux.

Anonymous Patient Answer

Has referral proven to be more effective than a placebo?

Referral was well received and the outcomes were encouraging, however, long-term follow-up data are needed to confirm the efficacy, compare a group of patients who received referral with a group of patients who did not receive the referral, to evaluate the impact on long-term survival.

Anonymous Patient Answer

What is referral?

Referral to other medical/surgical experts helps surgeons in decision making regarding patient care. A referral to a specific surgeon should be in the hands of one provider in order to avoid duplication of work or improper assignment of surgeons and patients.

Anonymous Patient Answer

What does referral usually treat?

The most commonly discussed topics, and thus the most common conditions referred for homeopathic care were pain management, cancer, and fatigue. The most frequently requested treatments had a wide scope of possibilities such as chemotherapy, chemotherapy agents, and targeted therapies. The most commonly requested diagnostic tests, which also often have specific treatment options, were MRI/CT, ultrasound, bloodwork, bone marrow biopsy, and X-rays. Homeopathic students must be aware of what is most often referred to homeopathic care and start to recognize these common topics/conditions/procedures as their scope of practice. Homeopathic doctors need to also be aware of the treatment options available for these and need to help patients understand the alternatives.

Anonymous Patient Answer

What is the average age someone gets cancer?

The average age is 52.6 years old. Older cancer patients are in better condition (having been treated less aggressively) and have earlier symptoms than younger ones. However, the average age is 51.5 year old as a pre-cancer patient, a large number of them have developed prostate cancer. Therefore, even if the average age is 52.6, it is better to be informed of the age when it's found, in order to get appropriate treatment. There are two different types of breast cancer and it’s advisable to consult a specialist as far as their specific type are concerned. They are the pre-cancer and cancer patients.

Anonymous Patient Answer
See if you qualify for this trial
Get access to this novel treatment for Cancer by sharing your contact details with the study coordinator.